Acetic Acid

Acetic Acid

SCHEMBL28308129

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Pd+2].[Pd+2]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.89
CA4 P22748 3/20 0.58
LMNA P02545 2/20 0.50
TSHR P16473 2/20 0.46
THPO P40225 1/20 0.46
FFAR3 O14843 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
ALOX15 P16050 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
FAHD1 Q6P587 1/20 0.42
ALDH1A1 P00352 4/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CA2 P00918 1/20 0.36
PTGS1 P23219 1/20 0.36
MMP12 P39900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL711 1.00
Acetic Acid SCHEMBL8027888 1.00 CA1 (0.89) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL3805081 1.00 CA1 (0.89) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL19518030 1.00 CA1 (0.89) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL29827597 1.00 CA1 (0.89) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL3432478 1.00 CA1 (0.89) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL11766161 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL2299205 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL1807960 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL8105341 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117567514-A Method for preparing spiro phosphine ligand 凯特立斯(深圳)科技有限公司 2024-02-20 CN claimed
CN-116655588-A Sulfur-substituted thiophene intermediate compound and preparation method and application thereof 天津大学 2023-08-29 CN claimed
CN-115124491-A Preparation method of cyclododecane oxide and cyclododecanone 中国科学院上海有机化学研究所 2022-09-30 CN claimed
US-20250255172-A1 Organic Compound, Light-Emitting Device, and Display Apparatus SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-08-07 US disclosed
US-20250109116-A1 ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS HODOGAYA CHEMICAL CO., LTD. (JP) 2025-04-03 US disclosed
CN-119403813-A Organic compound, light-emitting device, and display device 株式会社半导体能源研究所 2025-02-07 CN disclosed
EP-4438590-A1 ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Hodogaya Chemical Co., Ltd. (JP) 2024-10-02 EP disclosed
CN-118284595-A Arylamine compound, organic electroluminescent element, and electronic device 保土谷化学工业株式会社 2024-07-02 CN disclosed
CN-118043308-A Bond formation method based on coupling reaction 中外制药株式会社 2024-05-14 CN disclosed
CN-116655588-B Sulfur-substituted thiophene intermediate compound and preparation method and application thereof 天津大学 2024-03-26 CN disclosed
CN-113348170-B Biphenyl derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-12-22 CN disclosed
WO-2023199152-A1 ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, AND DISPLAY DEVICE 株式会社半導体エネルギー研究所 2023-10-19 WO disclosed
CN-116655588-A Sulfur-substituted thiophene intermediate compound and preparation method and application thereof 天津大学 2023-08-29 CN disclosed
CN-111484480-B Polycyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-08-11 CN disclosed
CN-116396471-A Ext> IIGext> -ext> Aext> doubleext> -ext> receptorext> conjugatedext> polymerext> andext> syntheticext> methodext> thereofext> 中国科学院成都有机化学有限公司 2023-07-07 CN disclosed
WO-2023095844-A1 ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 保土谷化学工業株式会社 2023-06-01 WO disclosed
CN-111727186-B Biheterocyclic substituted pyridine-2 (1H) -ketone derivative, preparation method and medical application thereof 上海海雁医药科技有限公司 2022-11-08 CN disclosed
CN-107922347-B Novel imide derivatives and their use as pharmaceuticals 田边三菱制药株式会社 2022-06-28 CN disclosed
CN-114672003-A Conjugated polymer based on thiophene [3,4-c ] pyrrole-4, 6-diketone structure and preparation method and application thereof 天津理工大学 2022-06-28 CN disclosed
CN-110054541-A A kind of preparation method of deuterated aromatic compound 安徽秀朗新材料科技有限公司 2019-07-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250255172-A1 Organic Compound, Light-Emitting Device, and Display Apparatus CCND1, CCND2, CCNL2 CA1 4178/4885CA4 3670/4885LMNA 3501/4885
US-20250109116-A1 ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS SLC7A5, SLC43A1, SLC7A1 CA1 4867/4885CA4 4818/4885LMNA 3968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.